Company profilePharmaceutical#301 of 1,318 in Pakistan✓ No DRAP alerts

ALSON PHARMACEUTICALS

Pharmaceutical company · 59 brands · 56 molecules

Ranked #30 of 57 companies in Vitamin A, D & Combinations

59 registered products 27 pharmaceutical brands 56 distinct molecules 0 DRAP alerts

Company overview

59
registered products
27
pharmaceutical brands
56
distinct molecules
2
therapeutic classes
0
DRAP alerts

ALSON PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 59 product registrations across 56 distinct molecules. Its portfolio is concentrated in Vitamin A, D & Combinations and Quinolone Antibacterials. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Diclofenac4 brands
Folic Acid3 brands
Paracetamol2 brands
Artemether2 brands
Naproxen2 brands
Cefixime2 brands
Ketoprofen2 brands
Amoxicillin2 brands
Iron Salts2 brands

Therapeutic classes

Vitamin A, D & Combinations · 1Quinolone Antibacterials · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for ALSON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.